Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis

Abstract Background The 17-gene Genomic Prostate Score (GPS) test has been clinically employed to predict adverse prognosis in prostate cancer. In this meta-analysis, we aimed to evaluate the prognostic value of the 17-gene GPS in patients with prostate cancer. Methods Potentially relevant studies w...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Feilun Cui, Xuan Tang, Changfeng Man, Yu Fan
Format: Article
Language:English
Published: BMC 2024-05-01
Subjects:
Genomic prostate score
Prostate cancer
Distant metastases
Biochemical recurrence
Prostate cancer–specific mortality
Meta-analysis
Online Access:https://doi.org/10.1186/s12885-024-12389-1

Internet

https://doi.org/10.1186/s12885-024-12389-1

Similar Items